What do we gain from the sixth coronary heart disease drug?
- PMID: 14644934
- PMCID: PMC286232
- DOI: 10.1136/bmj.327.7426.1237
What do we gain from the sixth coronary heart disease drug?
Comment in
-
Prevention of coronary heart disease: is a cure too expensive?BMJ. 2004 Feb 14;328(7436):405; author reply 405. doi: 10.1136/bmj.328.7436.405. BMJ. 2004. PMID: 14962888 Free PMC article. No abstract available.
Comment on
-
Coronary heart disease prevention: insights from modelling incremental cost effectiveness.BMJ. 2003 Nov 29;327(7426):1264. doi: 10.1136/bmj.327.7426.1264. BMJ. 2003. PMID: 14644970 Free PMC article.
References
-
- Berwick DM. Is it wise to promote “perfection” as a goal? Continuous Improvement 2003;(4). www.ihi.org/pursuingperfection/faqs/ci0601letter.asp (accessed 11 Nov 2003).
-
- Department of Health. Building a safer NHS for patients. London: DoH, 2001.
-
- National Quality Forum. Safe practices for better healthcare. Washington, DC: NQF, 2003.
-
- Standing Medical Advisory Committee. The use of statins. London: Department of Health, 1997.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources